To this aim, more GBM cell lines, as well as new approaches, are being evaluated, including COX-2-gene silencing in TMZ-resistant or -sensitive GBM cell lines, COX-2 transfection in COX-2 null GBM cells, and induction of TMZ-resistance in selected GBM cell lines. The gene discussed is PTGS2; the disease is glioblastoma.